Pathstone Holdings »

Springworks Therapeutics shares owned by Pathstone Holdings

Quarter-by-quarter ownership of Springworks Therapeutics (SWTX) shares owned by Pathstone Holdings from 13F filings

Historical chart of Pathstone Holdings investment in Springworks Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Springworks Therapeutics held by Pathstone Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Springworks Therapeutics by Pathstone Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $523k 16k 32.04
2024-06-30 $425k 11k 37.65

More positions owned by Pathstone Holdings

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Ishares Tr Core S&p Mcp Etf (IJH)
NVIDIA Corporation (NVDA)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Amazon (AMZN)
Coca-Cola Company (KO)
Vanguard Index Fds Large Cap Etf (VV)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Pathstone Holdings

Top funds holding Springworks Therapeutics

Vanguard Group
BlackRock
BlackRock
Deep Track Capital
T. Rowe Price Associates
Boxer Capital
State Street Corporation
Maverick Capital
Marshall Wace
Pictet Asset Management Holding SA
Geode Capital Management
Arrowpoint Asset Management
OrbiMed Advisors
Woodline Partners
Siren

View all funds holding Springworks Therapeutics